Urelle

Urelle Overview

Updated: 
Urelle is a brand name medication included in the following groups of medications: Belladonna alkaloids, tertiary amines, Other urologicals, OTHER ANTIBACTERIALS, Antidotes, Tests for gastric secretion. For more information about Urelle see its generics Hyoscyamine, Methenamine, Methylthioninium Chloride, Phenyl Salicylate

How was your experience with Urelle?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking Urelle?

What are you taking Urelle for?

Choose one
  • Other
  • Abnormalities, Drug-induced
  • Bacteriuria
  • Colic
  • Cyanosis
  • Cystitis
  • Herpes Simplex
  • Hyperhidrosis
  • Intraoperative Complications
  • Irritable Bowel Syndrome
  • Lithiasis
  • Muscle Rigidity
  • Pain
  • Peptic Ulcer
  • Poisoning
  • Rhinitis
  • Sialorrhea
  • Spasm
  • Tremor
  • Urinary Bladder, Neurogenic
  • Urinary Tract Infections

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did Urelle work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend Urelle to a friend?

Pill Images

{{ slide.name }}
pill-image {{ slide.name }}
Color: {{ slide.color }} Shape: {{ slide.shape }} Size: {{ slide.size }} Score: {{ slide.score }} Imprint: {{ slide.imprint }}
<<
Prev
{{ slide.number }} of {{ slide.total }}
>>
Next

Manufacturer

Generics

Urelle consists of multiple generic medications. The generic medications are listed below.

Hyoscyamine

For more information on this medication choose from the list of selections below.

Methenamine

For more information on this medication choose from the list of selections below.

Methylthioninium Chloride

For more information on this medication choose from the list of selections below.

Phenyl Salicylate

For more information on this medication choose from the list of selections below.

Urelle Drug Class

Updated: 
Source